Implantica Future Growth
Future criteria checks 2/6
Implantica's earnings are forecast to decline at 3.7% per annum while its annual revenue is expected to grow at 83% per year. EPS is expected to decline by 18.4% per annum.
Key information
-3.7%
Earnings growth rate
-18.4%
EPS growth rate
Medical Equipment earnings growth | 22.6% |
Revenue growth rate | 83.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 21 Feb 2024 |
Recent future growth updates
Recent updates
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Jul 26We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Mar 06We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
Aug 19We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
May 05We're Not Very Worried About Implantica's (STO:IMP A SDB) Cash Burn Rate
Jan 14We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Sep 26Implantica (STO:IMP A SDB) Is In A Strong Position To Grow Its Business
Jan 08Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 32 | -25 | N/A | N/A | 1 |
12/31/2025 | 10 | -47 | N/A | N/A | 1 |
12/31/2024 | 4 | -37 | N/A | N/A | 1 |
12/31/2023 | 1 | -24 | -24 | -20 | N/A |
9/30/2023 | 1 | -20 | -22 | -17 | N/A |
6/30/2023 | 1 | -20 | -23 | -16 | N/A |
3/31/2023 | 1 | -21 | -24 | -16 | N/A |
12/31/2022 | 1 | -21 | -25 | -16 | N/A |
9/30/2022 | 1 | -22 | -25 | -15 | N/A |
6/30/2022 | 1 | -21 | -24 | -16 | N/A |
3/31/2022 | 1 | -18 | -21 | -14 | N/A |
12/31/2021 | 0 | -15 | -17 | -11 | N/A |
9/30/2021 | 0 | -12 | -20 | -16 | N/A |
6/30/2021 | 0 | -13 | -14 | -11 | N/A |
3/31/2021 | 0 | -11 | -13 | -10 | N/A |
12/31/2020 | 0 | -10 | -12 | -10 | N/A |
9/30/2020 | 0 | -8 | -4 | -2 | N/A |
12/31/2019 | 0 | -5 | -6 | -4 | N/A |
12/31/2018 | 0 | -5 | -8 | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IMP A SDB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IMP A SDB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IMP A SDB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IMP A SDB's revenue (83% per year) is forecast to grow faster than the Swedish market (1.7% per year).
High Growth Revenue: IMP A SDB's revenue (83% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IMP A SDB's Return on Equity is forecast to be high in 3 years time